Who is accountable for protecting R&D data through M&A, and what evidence should they preserve?

Who owns R&D data protection when an M&A transaction changes the boundary?

Accountability should be shared, but not blurred. Security, compliance, and legal each own a different part of the control problem: protecting the data, preserving evidence, and ensuring the transaction record can withstand audit or dispute. In practice, one team must coordinate the response so the evidence trail stays intact across pre-close and post-close transitions.

The key point is that M&A creates a temporary control gap if teams assume the other side is keeping the record. R&D data often moves across systems, advisors, staging areas, and deal rooms, so the accountable owner must be able to prove who had access, what moved, and when ownership changed, not just say the transfer was “approved.”

Where that responsibility is formalised well, it becomes a governance function as much as a security function. The record must support insider-risk review, regulatory inquiry, and legal defensibility without requiring reconstruction from email, chat logs, or informal handoffs.

What evidence should be preserved across pre-close and post-close?

The evidence set should be narrow enough to retain reliably and broad enough to reconstruct the chain of custody. At minimum, preserve access records showing who could reach the R&D assets, movement records showing what was copied, exported, shared, or migrated, and ownership-change evidence showing when control passed from one entity to another.

That evidence should span the full pre-close and post-close period, not only the closing date itself. The risky zone is the transition window, when access is often expanded for diligence, integrations, or carve-out work, and later revoked or re-scoped after completion. A good record shows the state before the deal, the state during transition, and the state after the boundary changes.

For a strong audit trail, teams usually need timestamps, identity or role context, approval references, and the system of record for each event. If the evidence cannot answer who acted, under whose authority, on which dataset, and in what timeframe, it is incomplete for dispute resolution.

Why M&A makes R&D evidence retention a security and governance issue

R&D data protection during M&A sits at the intersection of insider risk, confidentiality, and transaction governance. The concern is not only accidental loss, but also unauthorised copying, retention disputes, and post-close arguments about whether information was shared under the right obligations.

In this setting, the failure mode is usually not a single obvious breach. It is fragmented custody: data is moved into a data room, exported to a buyer-side environment, or reviewed by advisors, then logs are incomplete or disappear during platform changes. That is why the evidence must be captured while the transaction is still active and systems are still available.

Preserved records also reduce the chance that teams rely on memory later. When a regulator, auditor, or legal team asks what happened to a specific dataset, the organisation needs a contemporaneous trail, not a recreated narrative built after systems have been reconfigured.

Risk and Threat Considerations

M&A activity often expands access faster than teams can govern it. That creates a period where insiders, deal advisors, or integration staff may legitimately need access, but the blast radius of a mistake or misuse is larger than normal because sensitive R&D material is being redistributed across organisational boundaries.

Failure mechanism: Access is widened, transfers are only partially logged, and ownership changes are recorded inconsistently, so the organisation cannot prove what was exposed, by whom, or under which entity’s control once the transaction closes.

Impact: The result can be lost confidentiality, weakened legal defensibility, audit findings, and a costly inability to answer disputes or regulatory questions without reconstructing evidence from scratch.

Practitioner Guidance

What to verify: Confirm that one named function owns the evidence trail end to end, even if security, compliance, and legal all contribute. The owner should be able to produce access logs, transfer records, and ownership-change evidence without depending on post-hoc reconstruction.

What good looks like: The organisation can show a continuous chain of custody for each material R&D asset across the deal timeline, including who accessed it, what changed, and when responsibility moved from seller to buyer or to a shared transition environment.

Common mistake: Treating closing-day approvals as sufficient evidence. Approval of the transaction is not the same as proof of data handling, and once logs age out or systems are merged, the gap is hard to close.

Practitioner takeaway: In M&A, the real control objective is not just permission to share R&D data, but defensible proof of how that data was handled before, during, and after the ownership change.

Related resources from NHI Mgmt Group

• Who should be accountable for protecting connected devices and the data they generate?
• Why is it important to integrate identity and data governance?
• What is the difference between protecting applications and protecting access?
• Who is accountable when a non-human identity deletes production data through a valid token?